191 related articles for article (PubMed ID: 17189226)
21. Hyperamylasemia and acute pancreatitis after pancreatoduodenectomy: Two different entities.
Loos M; Strobel O; Dietrich M; Mehrabi A; Ramouz A; Al-Saeedi M; Müller-Stich BP; Diener MK; Schneider M; Berchtold C; Feisst M; Hinz U; Mayer P; Giannakis A; Schneider D; Weigand MA; Büchler MW; Hackert T
Surgery; 2021 Feb; 169(2):369-376. PubMed ID: 32981689
[TBL] [Abstract][Full Text] [Related]
22. High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.
Asano-Mori Y; Oshima K; Sakata-Yanagimoto M; Nakagawa M; Kandabashi K; Izutsu K; Hangaishi A; Motokura T; Chiba S; Kurokawa M; Hirai H; Kanda Y
Bone Marrow Transplant; 2005 Nov; 36(9):813-9. PubMed ID: 16151428
[TBL] [Abstract][Full Text] [Related]
23. Postoperative hyperamylasemia (POH) and acute pancreatitis after pancreatoduodenectomy (POAP): State of the art and systematic review.
Bannone E; Andrianello S; Marchegiani G; Malleo G; Paiella S; Salvia R; Bassi C
Surgery; 2021 Feb; 169(2):377-387. PubMed ID: 32641279
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
Nicholson VA; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey GP; Goodrich JM
Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
[TBL] [Abstract][Full Text] [Related]
25. [Cytomegaloviral infection in patients with hemoblastoses].
Savchenko VG; Troitskaia VV; Misiurin AV; Parovichnikova VN; Isaev VG; Mendeleeva LP; Liubimova LS; Demidova IA; Aksenova EV; Filatov FP
Ter Arkh; 2003; 75(7):52-8. PubMed ID: 12934482
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of hyperamylasemia in organophosphate poisoning.
Lee WC; Yang CC; Deng JF; Wu ML; Ger J; Lin HC; Chang FY; Lee SD
J Toxicol Clin Toxicol; 1998; 36(7):673-81. PubMed ID: 9865235
[TBL] [Abstract][Full Text] [Related]
27. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
28. Hyperamylasemia is associated with increased intestinal permeability in patients undergoing diagnostic oral double-balloon enteroscopy.
Feng N; Dai J; Lu H; Li XB; Gao YJ; Ge ZZ
World J Gastroenterol; 2014 Jan; 20(2):539-45. PubMed ID: 24574723
[TBL] [Abstract][Full Text] [Related]
29. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
[TBL] [Abstract][Full Text] [Related]
30. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
31. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA.
Ohta H; Matsuda Y; Tokimasa S; Sawada A; Kim JY; Sashihara J; Amo K; Miyagawa H; Tanaka-Taya K; Yamamoto S; Tano Y; Aono T; Yamanishi K; Okada S; Hara J
Bone Marrow Transplant; 2001 Jun; 27(11):1141-5. PubMed ID: 11551024
[TBL] [Abstract][Full Text] [Related]
32. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
33. A short-term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantation.
Dahiya D; Lee CF; Chan KM; Wu TJ; Chou HS; Cheng SS; Lee WC
J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):32-8. PubMed ID: 20499109
[TBL] [Abstract][Full Text] [Related]
34. Natural history of pancreatic involvement in paediatric inflammatory bowel disease.
Martinelli M; Strisciuglio C; Illiceto MT; Cardile S; Guariso G; Vignola S; Aloi M; D'Altilia MR; Alvisi P; Salvatore S; Staiano A; Cucchiara S; Miele E;
Dig Liver Dis; 2015 May; 47(5):384-9. PubMed ID: 25704068
[TBL] [Abstract][Full Text] [Related]
35. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
[TBL] [Abstract][Full Text] [Related]
36. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
[TBL] [Abstract][Full Text] [Related]
37. Development of intrapancreatic abscess--a consequence of CMV pancreatitis?
Bäckman L; Brattström C; Reinholt FP; Andersson J; Tydén G
Transpl Int; 1991 Jun; 4(2):116-21. PubMed ID: 1654918
[TBL] [Abstract][Full Text] [Related]
38. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Zhao XS; Yu L; Han W; Zhang XH; Wang Y; Chen Y; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):77-81. PubMed ID: 19563015
[TBL] [Abstract][Full Text] [Related]
39. Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors.
Shimokawa T; Morishima Y; Kitaori K; Kato C; Sao H
Int J Hematol; 1999 Aug; 70(2):119-26. PubMed ID: 10497851
[TBL] [Abstract][Full Text] [Related]
40. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
